Theopilus Thepen

Title: Theopilus Thepen: Innovator in Microtubule-Modification Technology

Introduction

Theopilus Thepen is a notable inventor based in Munich, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of compounds that modify microtubules. His innovative work has the potential to impact therapeutic approaches for diseases characterized by proliferating cells.

Latest Patents

Theopilus Thepen holds a patent for a microtubule-modifying compound. This compound is formed from at least one component A, which comprises a binding domain for extracellular surface structures of a diseased proliferating cell. Upon binding, component A is internalized, and it also includes at least one component B, characterized as a polypeptide. This polypeptide's amino acid sequence comprises a microtubule-associated protein (MAP) or at least a partial sequence of the MAP, maintaining the binding function of the MAP to a microtubule. He has 1 patent to his name.

Career Highlights

Theopilus Thepen is associated with the Fraunhofer Gesellschaft zur Förderung der Angewandten Forschung e.V., a leading research organization in applied sciences. His work at this institution has allowed him to explore innovative solutions in biotechnology and contribute to advancements in medical research.

Collaborations

Theopilus has collaborated with esteemed colleagues such as Stefan Barth and Dmitrij Hristodorov. These partnerships have fostered a collaborative environment that enhances the research and development of new technologies.

Conclusion

Theopilus Thepen is a pioneering inventor whose work in microtubule-modifying compounds showcases his commitment to advancing biotechnology. His contributions are poised to make a significant impact in the field of medical research and treatment.